{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T07:00:55Z","timestamp":1783148455204,"version":"3.54.6"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>To compare pneumatic vitreolysis and pars plana vitrectomy in the management of focal symptomatic vitreomacular traction (VMT).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Method:<\/jats:title>\n            <jats:p>Patients aged 18 years or older, with idiopathic focal symptomatic VMT and best-corrected visual acuity &lt;20\/40, without any other retinal pathology were randomized to undergo pneumatic vitreolysis (Group 1) or pars plana vitrectomy (Group 2). The primary outcome measure was resolution of traction confirmed with optical coherence tomography at 3 months. Secondary outcome measures were to compare changes in best-corrected visual acuity, central foveal thickness, and complications if any.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>A total of 30 eyes of 30 patients were included with 15 eyes in each group. Vitreomacular traction resolved successfully in 12 of 15 (80%) eyes in Group 1 and in all (100%) eyes in Group 2 (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.224). The mean visual acuity improved from 0.80 \u00b1 0.26 (20\/126 Snellen's equivalent) to 0.70 \u00b1 0.46 logMAR (20\/100 Snellen's equivalent) in Group 1 (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.71) and from 0.904 \u00b1 0.44 (20\/160 Snellen's equivalent) to 0.47 \u00b1 0.26 logMAR (20\/59 Snellen's equivalent) in Group 2 (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.0016). Although 4 of 15 (26.66%) eyes in Group 1 had formation of full-thickness macular hole and 7 eyes required resurgery (4 for full-thickness macular hole and 3 for unresolved VMT), none in the pars plana vitrectomy group had any complications requiring resurgery (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.0063). Two eyes in the pars plana vitrectomy group had intraoperative deroofing of the fovea leading to full-thickness macular hole.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Pars plana vitrectomy is better than pneumatic vitreolysis as a single intervention in the management of focal symptomatic VMT.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/iae.0000000000003456","type":"journal-article","created":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T19:07:46Z","timestamp":1645816066000},"page":"1277-1283","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["PNEUMATIC VITREOLYSIS VERSUS PARS PLANA VITRECTOMY IN FOCAL SYMPTOMATIC VITREOMACULAR TRACTION SYNDROME"],"prefix":"10.1097","volume":"42","author":[{"given":"Vinod","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ragini","family":"Sonkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1477-7975","authenticated-orcid":false,"given":"Saurabh","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shorya Vardhan","family":"Azad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohan","family":"Chawla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradeep","family":"Venkatesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajpal","family":"Vohra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atul","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250607","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1016\/j.ophtha.2013.07.042","article-title":"The international vitreomacular traction study group classification of vitreomacular adhesion, traction, and macular hole","volume":"120","author":"Duker","year":"2013","journal-title":"Ophthalmology"},{"key":"R2-20250607","first-page":"1","article-title":"A review of current management of vitreomacular traction and macular hole","volume":"2015","author":"Garc\u00eda-Layana","year":"2015","journal-title":"J Ophthalmol"},{"key":"R3-20250607","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1097\/IAE.0b013e31829232fd","article-title":"Symptomatic vitreomacular adhesion","volume":"3","author":"Jackson","year":"2013","journal-title":"Retina"},{"key":"R4-20250607","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0002-9394(14)73813-9","article-title":"Course of vitreomacular traction syndrome","volume":"119","author":"Hikichi","year":"1995","journal-title":"Am J Ophthalmol"},{"key":"R5-20250607","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/cxo.12019","article-title":"Spontaneous resolution of vitreomacular traction: a case series: spontaneous resolution of vitreomacular traction","volume":"96","author":"Selver","year":"2013","journal-title":"Clin Exp Optom"},{"key":"R6-20250607","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/eye.2008.36","article-title":"Pathological changes in the vitreoretinal junction 1: epiretinal membrane formation","volume":"22","author":"Snead","year":"2008","journal-title":"Eye (Lond)"},{"key":"R7-20250607","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s40123-016-0062-6","article-title":"Ocriplasmin for treatment of vitreomacular traction: an update","volume":"5","author":"Khan","year":"2016","journal-title":"Ophthalmol Ther"},{"key":"R8-20250607","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s00347-016-0322-9","article-title":"Pharmacological vitreolysis with ocriplasmin as a treatment option for symptomatic focal vitreomacular traction with or without macular holes (\u2264400 \u03bcm) compared to tranconjunctival vitrectomy [in German]","volume":"114","author":"Maier","year":"2017","journal-title":"Ophthalmologe"},{"key":"R9-20250607","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1097\/IAE.0000000000001448","article-title":"Pneumatic vitreolysis for relief OF vitreomacular traction","volume":"37","author":"Chan","year":"2017","journal-title":"Retina"},{"key":"R10-20250607","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1055\/s-2003-38191","article-title":"Vitrectomy for vitreo-macular traction syndrome [in French]","volume":"220","author":"Petropoulos","year":"2003","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"R11-20250607","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/j.ophtha.2010.01.041","article-title":"High-resolution optical coherence tomography after surgery for vitreomacular traction","volume":"117","author":"Sayegh","year":"2010","journal-title":"Ophthalmology"},{"key":"R12-20250607","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1023\/A:1002412323399","article-title":"Vitrectomy for macular pucker and vitreomacular traction syndrome","volume":"97","author":"Koerner","year":"1999","journal-title":"Doc Ophthalmol"},{"key":"R13-20250607","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/ICB.0000000000000120","article-title":"Severe acute vision loss, dyschromatopsia, and changes in the ellipsoid zone on SD-OCT associated with intravitreal ocriplasmin injection","volume":"9","author":"Quezada Ruiz","year":"2015","journal-title":"Retin Cases Brief Rep"},{"key":"R14-20250607","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1097\/IAE.0000000000000519","article-title":"Safety profile of ocriplasmin for symptomatic vitreomacular adhesion: a comprehensive analysis of premarketing and postmarketing experiences","volume":"35","author":"Hahn","year":"2015","journal-title":"Retina"},{"key":"R15-20250607","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0161-6420(95)30958-X","article-title":"Treatment of idiopathic macular holes by induced posterior vitreous detachment","volume":"102","author":"Chan","year":"1995","journal-title":"Ophthalmology"},{"key":"R16-20250607","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/eye.2016.231","article-title":"Pneumatic release of focal vitreomacular traction","volume":"31","author":"Claus","year":"2017","journal-title":"Eye (Lond)"},{"key":"R17-20250607","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ajo.2012.08.018","article-title":"Intravitreal injection of expansile perfluoropropane (c(3)f(8)) for the treatment of vitreomacular traction","volume":"155","author":"Rodrigues","year":"2013","journal-title":"Am J Ophthalmol"},{"key":"R18-20250607","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.ajo.2006.05.062","article-title":"Optical coherence tomography evaluation of idiopathic macular hole treatment by gas-assisted posterior vitreous detachment","volume":"142","author":"Jorge","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"R19-20250607","first-page":"182","article-title":"Treatment of vitreomacular traction with intravitreal injection of perfluoropropane","volume":"75","author":"Veith","year":"2020","journal-title":"Cesk Slov Oftalmol"},{"key":"R20-20250607","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ajo.2012.10.016","article-title":"How should we release vitreomacular traction: surgically, pharmacologically, or pneumatically?","volume":"155","author":"Johnson","year":"2013","journal-title":"Am J Ophthalmol"},{"key":"R21-20250607","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/IAE.0000000000000760","article-title":"Intravitreal sulfur hexafluoride injection for the treatment of vitreomacular traction syndrome","volume":"36","author":"Day","year":"2016","journal-title":"Retina"},{"key":"R22-20250607","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/IAE.0000000000001237","article-title":"Treatment of vitreomacular traction with intravitreal perfluoropropane (C3F8) injection","volume":"37","author":"Steinle","year":"2017","journal-title":"Retina"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000003456","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T18:00:46Z","timestamp":1749319246000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000003456"}},"subtitle":["A Randomized Trial"],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":22,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000003456","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]}}}